Actively Recruiting
Towards Personalized Medicine for Refractory/Relapsed Follicular Lymphoma Patients: the Cantera/Lupiae Registry
Led by European Hematology Association - Lymphoma Group · Updated on 2020-10-14
500
Participants Needed
11
Research Sites
365 weeks
Total Duration
On this page
Sponsors
E
European Hematology Association - Lymphoma Group
Lead Sponsor
A
Associazione Angela Serra per la ricerca sul cancro
Collaborating Sponsor
AI-Summary
What this Trial Is About
The optimal treatment strategy in patients with early progressive disease is not well known. In recent years, novel insights into the biology of Follicular Lymphoma (FL), and especially the role of the microenvironment, have resulted in the development of multiple novel treatment modalities. These new agents may ultimately improve the outlook for patients with FL with an unfavorable course, but for the development of the optimal therapeutic strategy, knowledge on the clinical and biological determinants of early refractory FL is needed.
CONDITIONS
Official Title
Towards Personalized Medicine for Refractory/Relapsed Follicular Lymphoma Patients: the Cantera/Lupiae Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with initial diagnosis of follicular lymphoma, refractory/relapsed/transformed after first line therapy
- All stages at the time of relapse
- Histological grade 1-3a at the time of initial diagnosis
- Age over 18 years
- Availability of clinical data, including baseline information, comorbidities, data on disease localization, laboratory parameters at staging, features of treatment adopted and assurance of follow-up updating as requested
- Diagnostic material available for review
- Written informed consent
You will not qualify if you...
- Age < 18 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 11 locations
1
Klinički Bolnički Centar Split
Split, Croatia, 21000
Actively Recruiting
2
AOU Città della Salute e della Scienza di Torino
Torino, Italy, 10126
Actively Recruiting
3
Academic Medical Center
Amsterdam, Netherlands, 1105 AZ
Actively Recruiting
4
University Medical Center Groningen
Groningen, Netherlands, 9713 GZ
Actively Recruiting
5
Instituto Português de Oncologia Francisco Gentil
Lisbon, Portugal
Actively Recruiting
6
Hospital Clinic de Barcelona
Barcelona, Spain, 08036
Actively Recruiting
7
Hospital 12 de Octubre
Madrid, Spain, 28041
Actively Recruiting
8
Hospital Jose Maria Morales Meseguer
Murcia, Spain, 30008
Actively Recruiting
9
Hospital de Son Llàtzer
Palma, Spain, 07198
Actively Recruiting
10
Hospital Universitario de Salamanca
Salamanca, Spain, 37007
Actively Recruiting
11
Kiev National Cancer Institute
Kiev, Ukraine, 03022
Actively Recruiting
Research Team
S
Sanne Tonino, MD
CONTACT
I
Irene Dogliotti, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here